INNOCIMAB PTE LTD has a total of 11 patent applications. Its first patent ever was published in 2016. It filed its patents most often in Australia, Brazil and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are EVAXION BIOTECH APS, VIVENTIA BIO INC and ADVANCED PROTEOME THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 1 | |
#2 | Brazil | 1 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Mexico | 1 | |
#8 | Philippines | 1 | |
#9 | Singapore | 1 | |
#10 | United States | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Analysing materials | |
#4 | Measuring microorganism processes | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Bach Ferdinand | 10 |
#2 | Schlegel Frank | 9 |
#3 | De Dosso Sara | 9 |
#4 | Kerkhoff Andrea | 9 |
#5 | Goker Erdem | 9 |
#6 | Kneba Michael | 9 |
#7 | Reuter Dirk | 9 |
#8 | Dommach Markus | 9 |
#9 | Hofheinz Ralf | 9 |
#10 | Schultheis Beate | 9 |
Publication | Filing date | Title |
---|---|---|
WO2017017133A1 | Treatment of patients diagnosed with pancreatic ductal adenocarcinoma using monoclonal antibodies against the epidermal growth factor receptor (egfr) |